Position in AVIR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,683,655
-$1,433,481 QoQ
Shares Held
1,652,399
-2.5% QoQ
Ownership
2.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. AVIR ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,683,655 | 1,652,399 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $9,117,136 | 1,694,635 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,370,547 | 1,784,467 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,173,530 | 1,783,976 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,395,043 | 1,776,401 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,294,357 | 1,770,688 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,983,361 | 1,786,078 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,807,178 | 1,733,486 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,699,555 | 1,721,920 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,780,667 | 1,678,383 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,971,612 | 1,630,037 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,518,711 | 1,506,237 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,734,497 | 1,533,288 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,242,178 | 1,863,337 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,320,481 | 1,937,730 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $10,781,047 | 1,894,736 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $12,803,912 | 1,803,368 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $13,516,374 | 1,872,074 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $20,789,549 | 2,325,453 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $38,665,991 | 1,102,852 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,658,755 | 961,767 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,569,295 | 284,523 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $9,303,319 | 222,674 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||